-
Ex-Zimbabwe cricket captain Williams treated for 'drug addiction'
-
Padres ace Darvish to miss 2026 MLB season after surgery
-
Diaz hero and villain as Bayern beat PSG in Champions League showdown
-
Liverpool master Real Madrid on Alexander-Arnold's return
-
Van de Ven back in favour as stunning strike fuels Spurs rout
-
Juve held by Sporting Lisbon in stalling Champions League campaign
-
New lawsuit alleges Spotify allows streaming fraud
-
Stocks mostly drop as tech rally fades
-
LIV Golf switching to 72-hole format in 2026: official
-
'At home' Djokovic makes winning return in Athens
-
Manchester City have become 'more beatable', says Dortmund's Gross
-
Merino brace sends Arsenal past Slavia in Champions League
-
Djokovic makes winning return in Athens
-
Napoli and Eintracht Frankfurt in Champions League stalemate
-
Arsenal's Dowman becomes youngest-ever Champions League player
-
Cheney shaped US like no other VP. Until he didn't.
-
Pakistan edge South Africa in tense ODI finish in Faisalabad
-
Brazil's Lula urges less talk, more action at COP30 climate meet
-
Barca's Lewandowski says his season starting now after injury struggles
-
Burn urges Newcastle to show their ugly side in Bilbao clash
-
French pair released after 3-year Iran jail ordeal
-
EU scrambles to seal climate targets before COP30
-
Getty Images largely loses lawsuit against UK AI firm
-
Cement maker Lafarge on trial in France over jihadist funding
-
Sculpture of Trump strapped to a cross displayed in Switzerland
-
Pakistan's Rauf and Indian skipper Yadav punished over Asia Cup behaviour
-
Libbok welcomes 'healthy' Springboks fly-half competition
-
Reeling from earthquakes, Afghans fear coming winter
-
Ronaldo reveals emotional retirement will come 'soon'
-
Munich's surfers stunned after famed river wave vanishes
-
Iran commemorates storming of US embassy with missile replicas, fake coffins
-
Gauff sweeps Paolini aside to revitalise WTA Finals defence
-
Shein vows to cooperate with France in probe over childlike sex dolls
-
Young leftist Mamdani on track to win NY vote, shaking up US politics
-
US government shutdown ties record for longest in history
-
King Tut's collection displayed for first time at Egypt's grand museum
-
Typhoon flooding kills over 40, strands thousands in central Philippines
-
Trent mural defaced ahead of Liverpool return
-
Sabalenka to face Kyrgios in 'Battle of Sexes' on December 28
-
Experts call for global panel to tackle 'inequality crisis'
-
Backed by Brussels, Zelensky urges Orban to drop veto on EU bid
-
After ECHR ruling, Turkey opposition urges pro-Kurd leader's release
-
Stocks drop as tech rally fades
-
UK far-right activist Robinson cleared of terror offence over phone access
-
World on track to dangerous warming as emissions hit record high: UN
-
Nvidia, Deutsche Telekom unveil 1-bn-euro AI industrial hub
-
Which record? Haaland warns he can get even better
-
Football star David Beckham hails knighthood as 'proudest moment'
-
Laurent Mauvignier wins France's top literary award for family saga
-
Indian Sikh pilgrims enter Pakistan, first major crossing since May conflict
US Supreme Court rejects bid to restrict abortion pill
The US Supreme Court on Thursday rejected a bid to restrict an abortion pill widely used in the United States to terminate pregnancies.
The court, in a unanimous opinion, said the anti-abortion groups and physicians challenging the medication, mifepristone, lacked the legal standing to bring the case.
Abortion rights are one of the key issues in the November election and the administration of Democratic President Joe Biden had urged the court to maintain access to the drug, which was approved by the Food and Drug Administration (FDA) in 2000. His opponent Donald Trump leads a Republican Party broadly favoring blocks to abortion access.
The mifepristone case was the first significant abortion case heard by the conservative-dominated Supreme Court since it overturned the previously long-held constitutional right to abortion two years ago.
"We recognize that many citizens, including the plaintiff doctors here, have sincere concerns about and objections to others using mifepristone and obtaining abortions," said Justice Brett Kavanaugh, who wrote the 9-0 opinion.
"But citizens and doctors do not have standing to sue simply because others are allowed to engage in certain activities," Kavanaugh said. "The plaintiffs lack standing to challenge FDA's actions."
The conservative justice said the federal courts were "the wrong forum for addressing the plaintiffs' concerns about FDA's actions" and they could present their objections through regulatory procedures or through the "political and electoral processes."
Abortion opponents have been seeking to restrict nationwide access to the pill, claiming it is unsafe and that anti-abortion doctors were being forced to violate their conscience by intervening on patients who suffered complications after using it.
A conservative US district court judge in Texas, who was appointed during Trump's presidency, issued a ruling last year that would have banned mifepristone.
An appeals court overturned the outright ban because the statute of limitations on challenging the FDA's approval had expired, but restricted access to the drug.
The appeals court reduced the period during which mifepristone can be used from 10 weeks of pregnancy to seven weeks, blocked it from being delivered by mail, and required the pill to be prescribed and administered by a doctor.
The Supreme Court ruling lifts those restrictions.
Medication abortion accounted for 63 percent of the abortions in the country last year, up from 53 percent in 2020, according to the Guttmacher Institute.
Some 20 states have banned or restricted abortion since the Supreme Court in June 2022 overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century.
Polls show a majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure or ban it outright.
N.Shalabi--SF-PST